Novartis – science based innovation for better patient outcomes

Primary tabs

Novartis – science based innovation for better patient outcomes

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Content from this campaign

Novartis Renews Drug Donation of Egaten® (Triclabendazole) Until 2022, Reaffirming Its Commitment to the Fight Against Liver Fluke
Novartis extends agreement with the WHO for the donation of Egaten® for the treatment of liver fluke, a neglected tropical disease, also known as fascioliasis, that infects more than 2.4 million people globally1 Since the start of the donation program in 2005, Novartis has donated approximately 4 million tablets of Egaten, valued at...
Jul 23, 2018 12:00 PM ET
Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
Alcon, the global leader in eye care and a division of Novartis, today announced Alcon Cares Project 100, which aims to reduce cataract blindness by providing equipment to perform phacoemulsification (or “phaco”), a key step in the cataract surgery procedure. Alcon Cares, a foundation that oversees equipment and product donations to those in need, will give 100 reprocessed Infiniti units to...
May 9, 2018 3:10 PM ET
Novartis Foundation Announces Implementation Partners for Better Hearts Better Cities Urban Health Initiative in São Paulo, Brazil
Less than three months after the selection of São Paulo, Brazil as the third city of the urban health initiative Better Hearts Better Cities, the Novartis Foundation announced the creation of a network of global and local implementation partners. They will co-design interventions to address São Paulo’s urban priorities to...
Apr 26, 2018 9:00 AM ET
Novartis Forms Alliance to Develop Medicines for Treating Infectious Diarrheal Disease
Novartis receives funding from Bill & Melinda Gates Foundation for further development of Novartis drug candidate KDU731 for the treatment of cryptosporidiosis Cryptosporidiosis is the second leading cause of infectious diarrhea in children Private companies, governments, non-governmental organizations, academia, and other stakeholders need to...
Feb 14, 2018 3:15 AM ET
Novartis Foundation Aims to Improve Cardiovascular Health as the Better Hearts Better Cities Initiative Gains Momentum Announcing New Partners and Confirming São Paulo as the Third City
Two new partners join the multisector initiative: the CDC Foundation and the American Heart Association. São Paulo, Brazil has been selected as a third city for Better Hearts Better Cities, following Ulaanbaatar, Mongolia and Dakar, Senegal. Better Hearts Better Cities has made significant progress in mobilizing a broad network of partners and...
Dec 14, 2017 7:00 AM ET

Pages